Wolverine Trading, LLC Gilead Sciences, Inc. Transaction History

Wolverine Trading, LLC

$83.2 Billion
Q1 2025

A detailed history of Wolverine Trading, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Wolverine Trading, LLC holds 39,705 shares of GILD stock, worth $4.31 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

39,705

Previous 21,115 88.04%

Holding current value

$4.31 Million

Previous $1.95 Million 128.1%

% of portfolio

0.01%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$89.14 - $117.41 $1.66 Million - $2.18 Million	18,590 Added 88.04%	39,705 $4.45 Million
Q4 2024 Feb 14, 2025	BUY	$83.95 - $97.9 $385,582 - $449,654	4,593 Added 27.8%	21,115 $1.95 Million
Q3 2024 Nov 14, 2024	SELL	$66.59 - $83.99 $2.27 Million - $2.86 Million	-34,036 Reduced 67.32%	16,522 $1.38 Million
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $1.44 Million - $1.66 Million	22,795 Added 82.11%	50,558 $3.47 Million
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $205,935 - $251,133	2,877 Added 11.56%	27,763 $2.03 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $1.28 Million - $1.45 Million	17,497 Added 236.8%	24,886 $2.02 Million
Q3 2023 Nov 15, 2023	SELL	$73.94 - $80.67 $429,443 - $468,531	-5,808 Reduced 44.01%	7,389 $553,000
Q2 2023 Aug 23, 2023	BUY	$76.01 - $86.7 $444,582 - $507,108	5,849 Added 79.6%	13,197 $1.02 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $568,073 - $647,211	7,348 New	7,348 $598,000
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $761,516 - $869,847	-12,790 Reduced 37.43%	21,378 $1.35 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $139,047 - $156,609	2,409 Added 7.59%	34,168 $2.14 Million
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $112,191 - $140,587	-1,937 Reduced 5.75%	31,759 $1.9 Million
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $4.29 Million - $4.87 Million	-66,074 Reduced 66.23%	33,696 $2.47 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $403,161 - $434,966	-5,956 Reduced 5.63%	99,770 $7.08 Million
Q2 2021 Aug 06, 2021	BUY	$63.47 - $69.35 $2.01 Million - $2.2 Million	31,676 Added 42.78%	105,726 $7.18 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $5.22 Million - $5.95 Million	-86,937 Reduced 54.0%	74,050 $4.85 Million
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $4.11 Million - $4.69 Million	72,637 Added 82.22%	160,987 $9.12 Million
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $2.19 Million - $2.75 Million	35,220 Added 66.29%	88,350 $5.49 Million
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $177,884 - $206,556	2,459 Added 4.85%	53,130 $3.96 Million
Q1 2020 May 11, 2020	SELL	$62.63 - $80.22 $8.02 Million - $10.3 Million	-128,007 Reduced 71.64%	50,671 $3.85 Million
Q4 2019 Feb 12, 2020	BUY	$61.62 - $67.78 $2.9 Million - $3.19 Million	47,108 Added 35.8%	178,678 $11.6 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $2.25 Million - $2.48 Million	35,989 Added 37.65%	131,570 $8.28 Million
Q2 2019 Aug 20, 2019	SELL	$61.87 - $69.38 $2.18 Million - $2.45 Million	-35,282 Reduced 26.96%	95,581 $6.46 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $4.34 Million - $4.86 Million	69,383 Added 112.85%	130,863 $8.51 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $3.3 Million - $4.3 Million	54,471 Added 777.16%	61,480 $3.8 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $1.45 Million - $1.61 Million	-20,392 Reduced 74.42%	7,009 $541,000
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $17.9 Million - $21.8 Million	-245,829 Reduced 89.97%	27,401 $2.07 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $18.4 Million - $21.6 Million	259,106 Added 1834.51%	273,230 $19.6 Million
Q3 2017 Nov 15, 2017	BUY	$72.11 - $85.47 $1.02 Million - $1.21 Million	14,124	14,124 $1.14 Million

Others Institutions Holding GILD

# of Institutions

2,286

Shares Held

997M

Call Options Held

9.62M

Put Options Held

10M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $136B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account

Wolverine Trading, LLC Gilead Sciences, Inc. Transaction History